Тема
:
Интересные ссылки
Показать сообщение отдельно
#
781
10.10.2018, 22:52
Dr.Vad
Модератор форума по гематологии
Регистрация: 16.01.2003
Город: Хьюстон, Техас
Сообщений: 79,966
Поблагодарили 33,038 раз(а) за 31,393 сообщений
4 публикации в нейме про аспирин:
Aspirin use prevented serious vascular events in persons who had diabetes and no evident cardiovascular disease at trial entry, but it also caused major bleeding events. The absolute benefits were largely counterbalanced by the bleeding hazard.
[
Ссылки доступны только зарегистрированным пользователям
]
Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who received placebo and was attributed primarily to cancer-related death. In the context of previous studies, this result was unexpected and should be interpreted with caution.
[
Ссылки доступны только зарегистрированным пользователям
]
Тhe use of low-dose aspirin as a primary prevention strategy in older adults resulted in a significantly higher risk of major hemorrhage and did not result in a significantly lower risk of cardiovascular disease than placebo.
[
Ссылки доступны только зарегистрированным пользователям
]
Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate of major hemorrhage than placebo.
[
Ссылки доступны только зарегистрированным пользователям
]
__________________
Искренне,
Вадим Валерьевич.
Dr.Vad
Посмотреть профиль
Найти все сообщения от Dr.Vad